50
Participants
Start Date
November 30, 2011
Primary Completion Date
September 30, 2012
Study Completion Date
September 30, 2012
Sufentanil, Hydromorphone
Intraoperatively: Target controlled infusion with 0.4 ng/ml Sufentanil, Postoperatively: Patient-controlled analgesia with target-controlled infusion of Hydromorphone
Sufentanil, Hydromorphone
Intraoperatively: Target controlled infusion with 0.8 ng/ml Sufentanil, Postoperatively: Patient-controlled analgesia with target-controlled infusion of Hydromorphone
Department of Anesthesiology, University Hospital, Erlangen
German Federal Ministry of Education and Research
OTHER_GOV
University of Erlangen-Nürnberg Medical School
OTHER